5 Oct 2026, 08:50
Meetings & Governance—
ENPENTROPY NEURODYNAMICS LIMITED
Announcement history available from 1 August 2025
Fromto
2 Oct 2026, 15:16
Securities Administration—
15 Sept 2026, 08:43
Meetings & Governance—
14 Sept 2026, 08:40
Company UpdateMS
28 Aug 2026, 10:03
Presentations—
28 Aug 2026, 09:46
Company Administration—
28 Aug 2026, 09:44
Financial ResultsMS
26 Aug 2026, 09:57
Company UpdateMS
24 Aug 2026, 16:18
Securities Administration—
24 Aug 2026, 09:39
Trading Halt / SuspensionMS
19 Aug 2026, 08:20
Company UpdateMS
7 Aug 2026, 13:47
Director Interests—
7 Aug 2026, 09:49
Securities Administration—
7 Aug 2026, 09:44
Securities Administration—
7 Aug 2026, 08:53
Presentations—
4 Aug 2026, 09:10
Company UpdateMS
31 July 2026, 09:17
Trading Halt / SuspensionMS
27 July 2026, 09:12
Presentations—
24 July 2026, 14:06
Company Administration—
22 July 2026, 08:26
Quarterly ReportsMS
20 July 2026, 08:35
Company UpdateMS
10 July 2026, 09:07
Company Update—
9 July 2026, 11:13
Presentations—
7 July 2026, 09:37
Company UpdateMS
3 July 2026, 09:09
Trading Halt / SuspensionMS
26 June 2026, 12:29
Securities Administration—
26 June 2026, 12:25
Securities Administration—
25 June 2026, 17:27
Securities Administration—
25 June 2026, 17:12
Securities Administration—
15 June 2026, 09:55
Company UpdateMS
2 June 2026, 08:56
Company UpdateMS
29 May 2026, 11:07
Securities Administration—
22 May 2026, 13:32
Securities Administration—
15 May 2026, 13:46
Securities Administration—
14 May 2026, 09:23
Director Interests—
11 May 2026, 09:44
Presentations—
5 May 2026, 09:38
Company UpdateMS
4 May 2026, 09:08
Company UpdateMS
28 Apr 2026, 09:29
Quarterly ReportsMS
20 Apr 2026, 14:53
Director Interests—
17 Apr 2026, 16:45
Securities Administration—
17 Apr 2026, 16:40
Securities Administration—
14 Apr 2026, 10:49
Securities Administration—
14 Apr 2026, 10:47
Securities Administration—
14 Apr 2026, 09:29
Company UpdateMS
30 Mar 2026, 14:18
Securities Administration—
19 Mar 2026, 16:21
Meetings & Governance—
13 Mar 2026, 14:21
Securities Administration—
10 Mar 2026, 13:04
Director Interests—
10 Mar 2026, 12:09
Securities Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 08:50 | 2026 AGM Notice of Meeting, Letter of Access and Proxy | Meetings & Governance | — | 08001, 08004, 16002 | |
| 2 Oct 2026, 15:16 | Notification regarding unquoted securities - ENP | Securities Administration | — | 06021 | |
| 15 Sept 2026, 08:43 | Notification of Date of 2026 AGM | Meetings & Governance | — | 08006 | |
| 14 Sept 2026, 08:40 | All Patients Improve, 50% Achieve 12-Week BED Remission | Company Update | MS | 11001 | |
| 28 Aug 2026, 10:03 | Investor Webinar Presentation | Presentations | — | 03026 | |
| 28 Aug 2026, 09:46 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 28 Aug 2026, 09:44 | Appendix 4E and 2026 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 26 Aug 2026, 09:57 | Entropy Advances TRP-8803 to US Phase 2 in Depression | Company Update | MS | 09014, 11001, 14014 | |
| 24 Aug 2026, 16:18 | Application for quotation of securities - ENP | Securities Administration | — | 06020 | |
| 24 Aug 2026, 09:39 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 19 Aug 2026, 08:20 | TRP 8803 manufacturing secured for Phase 2/3 advancement | Company Update | MS | 11001 | |
| 7 Aug 2026, 13:47 | Change of Director's Interest Notice - HJ | Director Interests | — | 02009 | |
| 7 Aug 2026, 09:49 | Cleansing Notice | Securities Administration | — | 06018 | |
| 7 Aug 2026, 09:44 | Application for quotation of securities - ENP | Securities Administration | — | 06020 | |
| 7 Aug 2026, 08:53 | BioShares 2026 Investor Presentation Deck | Presentations | — | 03026 | |
| 4 Aug 2026, 09:10 | 72-Patient Trial Fast-Tracks TRP-8803 Commercialisation | Company Update | MS | 09014, 11001 | |
| 31 July 2026, 09:17 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 27 July 2026, 09:12 | Techknow Invest Roadshow presentation | Presentations | — | 03026 | |
| 24 July 2026, 14:06 | Appointment of Joint Company Secretary | Company Administration | — | 12007 | |
| 22 July 2026, 08:26 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19004, 19009 | |
| 20 July 2026, 08:35 | South Africa Grants ENP Broad Fibromyalgia Patent to 2043 | Company Update | MS | 11001 | |
| 10 July 2026, 09:07 | Additional Australian patent granted | Company Update | — | 11001 | |
| 9 July 2026, 11:13 | Investor Presentation | Presentations | — | 03026 | |
| 7 July 2026, 09:37 | 100% Clinical improvement, 50% Remission in BED study | Company Update | MS | 09014, 11001, 14014 | |
| 3 July 2026, 09:09 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 26 June 2026, 12:29 | Application for quotation of securities - ENP | Securities Administration | — | 06020 | |
| 26 June 2026, 12:25 | Top 20 Option Holders & Distribution Schedule | Securities Administration | — | 03002, 06009 | |
| 25 June 2026, 17:27 | Proposed issue of securities - ENP | Securities Administration | — | 06013 | |
| 25 June 2026, 17:12 | Short Form Prospectus | Securities Administration | — | 06009, 06010 | |
| 15 June 2026, 09:55 | DSMB Clears TRP 8803 to Advance to Cohort 2 | Company Update | MS | 11001 | |
| 2 June 2026, 08:56 | Entropy completes Cohort 1 dosing in BED trial | Company Update | MS | 11001 | |
| 29 May 2026, 11:07 | Application for quotation of securities - ENP | Securities Administration | — | 06020 | |
| 22 May 2026, 13:32 | Release of Securities from Escrow | Securities Administration | — | 06009 | |
| 15 May 2026, 13:46 | Notification of cessation of securities - ENP | Securities Administration | — | 06027 | |
| 14 May 2026, 09:23 | Change of Director's Interest Notice - JC | Director Interests | — | 02009 | |
| 11 May 2026, 09:44 | Australian Microcap Investment Conference presentation | Presentations | — | 03026 | |
| 5 May 2026, 09:38 | Entropy files new US patent for IBS program | Company Update | MS | 11001, 14014 | |
| 4 May 2026, 09:08 | TRP 8802 delivers 75% breakthrough response in IBS | Company Update | MS | 11001, 14014 | |
| 28 Apr 2026, 09:29 | Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19003, 19008 | |
| 20 Apr 2026, 14:53 | Change of Director's Interest Notice - CN, DT, JC & HJ | Director Interests | — | 02009 | |
| 17 Apr 2026, 16:45 | Cleansing Notice | Securities Administration | — | 06018 | |
| 17 Apr 2026, 16:40 | Application for quotation of securities - ENP | Securities Administration | — | 06020 | |
| 14 Apr 2026, 10:49 | Cleansing Notice | Securities Administration | — | 06018 | |
| 14 Apr 2026, 10:47 | Application for quotation of securities - ENP | Securities Administration | — | 06020 | |
| 14 Apr 2026, 09:29 | TRP-8803 delivers repeatable, high-intensity effect | Company Update | MS | 11001 | |
| 30 Mar 2026, 14:18 | Notification regarding unquoted securities - ENP | Securities Administration | — | 06021 | |
| 19 Mar 2026, 16:21 | Results of EGM | Meetings & Governance | — | 08003 | |
| 13 Mar 2026, 14:21 | Application for quotation of securities - ENP | Securities Administration | — | 06020 | |
| 10 Mar 2026, 13:04 | Change of Director's Interest Notice - JC | Director Interests | — | 02009 | |
| 10 Mar 2026, 12:09 | Application for quotation of securities - ENP | Securities Administration | — | 06020 |
1–50 of 74
1 / 2